After the Airgas, Inc. (NYSE: ARG) unsolicited offer from Air Products & Chemicals, Inc. (NYSE: APD) was made, we noticed how there was a premium to the deal’s public price. We even noted that Jefferies had given a potential scenario of $68.00. Now we know why rather than just suspect why. Airgas’ Board of Directors announced that the Air Products’ February 5 proposal AND the previously rejected $62 per share offer grossly undervalue Airgas. Based upon how the release was handled this week and based upon the news reports, it seemed that this first denial of an offer was certain.
Read More
RSS Updates
Email Updates
This past week was filled with many surprises and earnings are still coming on strong. We wanted to look at some companies that either have unfinished business or are on deck with pending news this coming week for our review of the Unusual Suspects. AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) has a rebuttal, Apple Inc. (NASDAQ: AAPL) needs to be watched like a hawk over the chart, Baidu, Inc. (NASDAQ: BIDU) is on deck with earnings, and Denny’s Corp. (NASDAQ: DENN) is another Super Bowl play. We have two issues in M&A with Airgas Inc. (NYSE: ARG) and then potentially in Micron Technology Inc. (NASDAQ: MU). And we have FDA events pending in Gilead Sciences Inc. (NASDAQ: GILD) and in XenoPort, Inc. (Nasdaq: XNPT).
Air Products & Chemicals Inc. (NYSE: APD) may have opened up a can of worms with its planned acquisition of Airgas Inc. (NYSE: ARG). For starters, Air Products has a market cap of $14.5 billion. Airgas has a market cap of almost $5 billion after the 40% gain since the deal was announced. This merger brings up many questions that have few answers.





